Press releases
NLS Pharmaceutics Announces Closing of $1.75 Million Registered Direct Offering
22 Mar 24
Offerings, Press Releases
NLS Pharmaceutics Announces $1.75 Million Registered Direct Offering
20 Mar 24
News, Press Releases
NLS Pharmaceutics Secures Exclusive Global License for Next-Generation Non-Sulfonamide Dual Orexin Agonist Platform
20 Mar 24
M&A, Press Releases
NLS Pharmaceutics to Participate in the BIO-EUROPE Springtime Partnering Event
14 Mar 24
Events, Press Releases
Nasdaq Accepts NLS Pharmaceutics' Plan to Regain Listing Compliance
11 Mar 24
Legal, Press Releases
NLS Pharmaceutics Submits Plan to Regain Listing Compliance With Nasdaq
23 Feb 24
Legal, Press Releases
Notice of Deficiency with Nasdaq Continued Listing Requirements
12 Jan 24
Legal, Press Releases
NLS Pharmaceutics CEO Issues Letter to Shareholders
29 Dec 23
News, Press Releases